Pfizer Ltd. (PFIZER) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Neuland Labs.

Emcure Pharma

J B Chemicals &

Astrazeneca Phar

ERIS Lifescience

Pfizer

Gland Pharma

Wockhardt

Cohance Life

Piramal Pharma

OneSource Speci.

Why is Pfizer Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 2.01% and Operating profit at 7.55% over the last 5 years

With ROE of 18.3, it has a Very Expensive valuation with a 5.9 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -5.47%, its profits have risen by 15.2% ; the PEG ratio of the company is 2.1
At the current price, the company has a high dividend yield of 3.3

Below par performance in long term as well as near term

Along with generating -5.47% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Pfizer for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Pfizer

-5.47%

-0.19

28.62%

Sensex

4.73%

0.40

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.01%

EBIT Growth (5y)

7.55%

EBIT to Interest (avg)

56.82

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.69

Sales to Capital Employed (avg)

0.74

Tax Ratio

24.60%

Dividend Payout Ratio

119.20%

Pledged Shares

Institutional Holding

19.71%

ROCE (avg)

49.32%

ROE (avg)

18.68%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.94

EV to EBIT

26.78

EV to EBITDA

24.81

EV to Capital Employed

17.00

EV to Sales

8.50

PEG Ratio

2.13

Dividend Yield

3.30%

ROCE (Latest)

63.46%

ROE (Latest)

18.32%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

OPERATING CF(Y)

Highest at Rs 659.75 Cr

PAT(Latest six months)

At Rs 380.77 cr has Grown at 23.20%

ROCE(HY)

Highest at 24.41%

DPS(Y)

Highest at Rs 165.00

DPR(Y)

Highest at 119.20%

NET SALES(Q)

Highest at Rs 642.34 cr

PBDIT(Q)

Highest at Rs 229.93 cr.

PBT LESS OI(Q)

Highest at Rs 213.52 cr.

-3What is not working for the Company

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.75 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 9.74 times

Loading Valuation Snapshot...

Here's what is working for Pfizer

Profit After Tax (PAT) - Latest six months

At Rs 380.77 cr has Grown at 23.20%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Operating Cash Flow - Annually

Highest at Rs 659.75 Cr

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Quarterly

Highest at Rs 642.34 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Highest at Rs 229.93 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

Highest at Rs 213.52 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 213.52 cr has Grown at 21.6% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 175.65 Cr

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Dividend per Share (DPS) - Annually

Highest at Rs 165.00

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (Rs)

Dividend Payout Ratio (DPR) - Annually

Highest at 119.20%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for Pfizer

Inventory Turnover Ratio- Half Yearly

Lowest at 4.75 times and Fallen

each half year in the last five half yearly periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio- Half Yearly

Lowest at 9.74 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio